XML 25 R14.htm IDEA: XBRL DOCUMENT v3.26.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 6 — Commitments and Contingencies

 

Registration Rights

 

The holders of the Founder Shares, Private Placement Units, representative shares and units that may be issued upon conversion of Working Capital Loans (and in each case holders of their component securities, as applicable) are entitled to registration rights pursuant to the registration rights agreement signed in connection with the Initial Public Offering requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A ordinary shares). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The registration rights agreement does not contain liquidated damages which would be included with respect to registration statements filed after a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Risks and Uncertainties

 

The Company’s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company’s control. The Company’s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, public sentiment and governmental decisions and policies related to data centers, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, changes in tariff policies, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company’s ability to complete an initial Business Combination.

 

 

Underwriting Agreement

 

The Company granted the underwriters a 45-day option from the date of Initial Public Offering to purchase up to 1,800,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The over-allotment option was exercised in full on October 6, 2025.

 

Advisory Engagement

 

On April 4, 2026, the Company engaged CMD Global Partners, LLC (“CMD”) to provide investment banking advisory services in connection with potential Business Combinations. The engagement provides for a $10,000 milestone fee upon a target’s acceptance of a qualifying non-binding offer, indication of interest or letter of intent, an additional and larger milestone fee upon execution of a definitive agreement for a transaction, and a success fee upon closing of a Business Combination which success fee is based, in part, on whether the transaction’s Aggregate Value (as defined in the engagement) exceeds a specified threshold. In the event the Company closes a private placement CMD would be due a fee based on the gross proceeds raised from investors introduced by CMD. During the nine months ended September 30, 2026, the Company paid the $10,000 milestone fee and $22,618 of due diligence travel expenses. No other CMD fees had been earned, and no CMD fees or reimbursable expenses are unpaid at September 30, 2026.

 

On August 10, 2026, the Company engaged Maxim Group LLC (“Maxim”) to provide financial advisory services in connection with potential Business Combinations with covered targets. For targets identified or introduced to the Company and agreed upon by the parties, the success fee is payable upon closing in common stock of the post-transaction company, at the same price per share or exchange ratio as the transaction consideration. The fee is calculated on a scaled basis, with successive portions of the target’s Aggregate Transaction Value (as defined in the engagement) entitling Maxim to a defined percentage of that value. For targets not identified or introduced by Maxim for which the Company requests assistance, and which the parties designate in writing, a success fee is payable. The engagement has a 12-month term, subject to certain termination rights and fees that extend beyond termination. At September 30, 2026, no advisory fees had been earned or paid under the August 2026 engagement and no fees or reimbursable expenses are unpaid.

 

A prior advisory engagement with a separate advisor was terminated in June 2026. The advisor retains certain fee rights following termination with respect to specified targets, none of which the Company is currently in discussions with. All retainers and reimbursable expenses of the advisor were settled by September 30, 2026, with no amounts outstanding or disputed at that date.